The oral hypoxia-inducible factor prolyl hydroxylase (HIF-PHI), roxadustat, is in last-stage development for the ... In the OLYMPUS trial, researchers examined the efficacy of roxadustat for the treatment of anemia in patients with ... Researchers, led by Ajay Sharma, conducted a study designed to develop and validate a predictive model to identify ... Worldwide, the prevalence of chronic kidney disease (CKD) is on the rise. In the United States, approximately 15% of the ... Washington, DC—Patients with gastroesophageal reflux disease and peptic ulcer disease are commonly treated with proton ... Hyperkalemia, an electrolyte abnormality, is common in patients with chronic kidney disease (CKD). Treatment for ... Patiromer, a sodium-free potassium binder approved for treating hyperkalemia in adults is not currently approved for use ... Increased excretion of urinary oxalate, enteric hyperoxaluria, can occur as a complication of fat malabsorption ... Washington, DC—Canagliflozin is US FDA approved for treatment of patients with type 2 diabetes and estimated ... Washington, DC—Patients with chronic kidney disease (CKD) who develop anemia may have reduced quality of life and ... Washington, DC—One of the earliest indicators of kidney disease is new-onset albuminuria, which is predicted by an ... Washington, DC—There is no association between the distance between a patient’s residence and a kidney transplant ... Washington, DC—The treatment of choice for patients with end-stage renal disease is kidney transplantation, and living ... Patients with chronic kidney disease (CKD) who develop metabolic acidosis are at risk for accelerated decline in ... Washington, DC—Varying definitions of chronic kidney disease (CKD) and diagnosis accuracy in medical records ... Tolvaptan is approved for the treatment of adult patients with autosomal dominant polycystic kidney disease (ADPKD). Patients with autosomal dominant polycystic kidney disease (ADPKD) at highest risk for disease progression The American College of Cardiology/American Heart Association (ACC/AHA) issued new hypertension guidelines in 2017 that ... Results of studies have suggested that chronic kidney disease (CKD) is an independent predictor of stroke; the studies ...